Category & trade
Primary
lung-and-respiratory-health · embed-ft 0.61
Tree path
Medical Health › Diseases and Conditions › Lung and Respiratory Health
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
48 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
About Autoimmune Pulmonary Alveolar Proteinosis (aPAP) - IMPALA-2
Description
(aPAP) is a rare lung disease that occurs most frequently in people between the ages of 30 and 40. Click to read more about our IMPALA-2 aPAP clinical trial.
Final URL
Language
en (html)
Scanned at
2026-06-23 05:55:38